+

WO2007056996A3 - Hypertension agent containing tribomechanically activated zeolites - Google Patents

Hypertension agent containing tribomechanically activated zeolites Download PDF

Info

Publication number
WO2007056996A3
WO2007056996A3 PCT/DE2006/002018 DE2006002018W WO2007056996A3 WO 2007056996 A3 WO2007056996 A3 WO 2007056996A3 DE 2006002018 W DE2006002018 W DE 2006002018W WO 2007056996 A3 WO2007056996 A3 WO 2007056996A3
Authority
WO
WIPO (PCT)
Prior art keywords
percent
weight
agent containing
hypertension agent
activated zeolites
Prior art date
Application number
PCT/DE2006/002018
Other languages
German (de)
French (fr)
Other versions
WO2007056996A2 (en
Inventor
Tihomir Lelas
Original Assignee
Ljubicic Mijo
Ivkovic Slavko
Tihomir Lelas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06090025A external-priority patent/EP1839666A1/en
Application filed by Ljubicic Mijo, Ivkovic Slavko, Tihomir Lelas filed Critical Ljubicic Mijo
Publication of WO2007056996A2 publication Critical patent/WO2007056996A2/en
Publication of WO2007056996A3 publication Critical patent/WO2007056996A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to pharmaceutical agents comprising 50 to 90 percent by weight of TMAZ, 1 to 30 percent by weight of ramson herb, 1 to 10 percent by weight of mistletoe herb, 1 to 10 percent by weight of silver linden blossoms, 1 to 10 percent by weight of hawthorn blossoms, and 1 to 10 percent by weight of ginkgo leaves. Also disclosed is the use of the pharmaceutical agent for treating diseases associated with hypertension.
PCT/DE2006/002018 2005-11-15 2006-11-14 Hypertension agent containing tribomechanically activated zeolites WO2007056996A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102005055328 2005-11-15
DE102005055328.1 2005-11-15
EP06090025A EP1839666A1 (en) 2006-02-15 2006-02-15 Composition for treating hypertension comprising tribomechanically activated zeolites
EP06090025.5 2006-02-15

Publications (2)

Publication Number Publication Date
WO2007056996A2 WO2007056996A2 (en) 2007-05-24
WO2007056996A3 true WO2007056996A3 (en) 2007-10-11

Family

ID=38048991

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2006/002018 WO2007056996A2 (en) 2005-11-15 2006-11-14 Hypertension agent containing tribomechanically activated zeolites

Country Status (1)

Country Link
WO (1) WO2007056996A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108355073A (en) * 2018-03-30 2018-08-03 甘肃大整健康管理股份有限公司 A kind of traditional Chinese medicine health care preparation for the lipoid and reducing blood pressure that disappears

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19755921A1 (en) * 1997-12-16 1999-06-17 Utp Dr Snyckers Gmbh Method and device for improving the effectiveness of active substances which consist at least of minerals
WO2000064586A1 (en) * 1999-04-26 2000-11-02 Tihomir Lelas Device for micronizing materials

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19755921A1 (en) * 1997-12-16 1999-06-17 Utp Dr Snyckers Gmbh Method and device for improving the effectiveness of active substances which consist at least of minerals
WO2000064586A1 (en) * 1999-04-26 2000-11-02 Tihomir Lelas Device for micronizing materials

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYM, INTERNET ARTIKEL, 2 March 2005 (2005-03-02), XP002387266, Retrieved from the Internet <URL:http://web.archive.org/web/20050302205630/http://vetera.de/vi-album.htm> [retrieved on 20060623] *
ANONYM, INTERNET ARTIKEL, 6 March 2005 (2005-03-06), XP002387265, Retrieved from the Internet <URL:http://web.archive.org/web/20050306014738/http://www.megamin.net/german/when.htm> [retrieved on 20060623] *
PREUSS H G ET AL: "Wild garlic has a greater effect than regular garlic on blood pressure and blood chemistries of rats.", INTERNATIONAL UROLOGY AND NEPHROLOGY. 2001, vol. 32, no. 4, 2001, pages 525 - 530, XP002387295, ISSN: 0301-1623 *
STEINMETZ E F, MATERIA MEDICA VEGETALIS, 1954, XP002387267, Retrieved from the Internet <URL:http://web.archive.org/web/20040104060621/http://www.heilpflanzen-suchmaschine.de/baerlauch/baerlauch_anwendung.shtml> [retrieved on 20060623] *
VOGEL J H K ET AL: "Integrating Complementary Medicine Into Cardiovascular Medicine", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, XX, XX, vol. 46, no. 1, 5 July 2005 (2005-07-05), pages 184 - 221, XP004962962, ISSN: 0735-1097 *
WINTHER KAJ ET AL: "Effects of Gingko biloba extract on cognitive function and blood pressure in elderly subjects", CURRENT THERAPEUTIC RESEARCH, vol. 59, no. 12, December 1998 (1998-12-01), pages 881 - 888, XP002387268, ISSN: 0011-393X *

Also Published As

Publication number Publication date
WO2007056996A2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
IL245489A0 (en) 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2005028475A3 (en) Compositions useful as inhibitors of protein kinases
EP2305640A3 (en) Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
WO2007064931A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
EP2537849A3 (en) Azaindoles useful as inhibitors of janus kinases
WO2007041130A3 (en) Deazapurines useful as inhibitors of janus kinases
WO2006124748A3 (en) Multicyclic compounds and methods of their use
WO2004074232A8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2004071382A3 (en) Substituted heterocycles
WO2005007142A3 (en) Liquid compositions comprising formoterol
HK1166983A1 (en) Solid forms comprising compounds for the treatment of diseases or disorders, compositions thereof, and use therewith
EP1935418A4 (en) COMPOSITION FOR ALLEVIATING FATIGUE SUBJECTIVE SYMPTOMS
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
WO2006002909A3 (en) Sphingolipids against pathological processes in lipid rafts
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
EP1900362A3 (en) Alfa-aminoamide derivatives useful in the treatment of addictive disorders
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
WO2004080373A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
WO2006126895A3 (en) Cognitive abilities improving agent
EP2017620A3 (en) Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (DPP1)
WO2007056996A3 (en) Hypertension agent containing tribomechanically activated zeolites
WO2007048034A3 (en) Use of androgens for the treatment of parkinson&#39; s disease
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
WO2003065044A3 (en) Diagnostics and therapeutics for diseases associated with gpr72

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase

Ref document number: 06828523

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载